Liraglutide Injection shortage
Current 11 presentations · 4 manufacturers · first FDA posting 2023-07-18 · last update 2026-10-14
Manufacturers: Hikma Pharmaceuticals USA, Inc., Meitheal Pharmaceuticals, Inc., Novo Nordisk, Inc., Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Delay in shipping of the drug; Discontinuation of the manufacture of the drug
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/18/2023 Updated 10/14/2026 | |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/18/2023 Updated 10/14/2026 | |
| Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84) | Meitheal Pharmaceuticals, Inc. | Current Available |
— | Posted 07/18/2023 Updated 08/27/2026 | |
| Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85) | Meitheal Pharmaceuticals, Inc. | Current Available |
— | Posted 07/18/2023 Updated 08/27/2026 | |
| Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Novo Nordisk, Inc. | Current Limited Availability |
Discontinuation of the manufacture of the drug | Product will be available until discontinuation in January 2027 | Posted 07/18/2023 Updated 09/22/2026 |
| Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) | Novo Nordisk, Inc. | Current Limited Availability |
Delay in shipping of the drug | Estimated shortage duration: TBD | Posted 07/18/2023 Updated 09/22/2026 |
| Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) | Novo Nordisk, Inc. | Current Limited Availability |
Delay in shipping of the drug | Estimated shortage duration: TBD | Posted 07/18/2023 Updated 09/22/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) | Novo Nordisk, Inc. | Current Available |
— | Distributed by Teva | Posted 07/18/2023 Updated 09/22/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) | Novo Nordisk, Inc. | Current Available |
— | Distributed by Teva | Posted 07/18/2023 Updated 09/22/2026 |
| Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Novo Nordisk, Inc. | To Be Discontinued | — | Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug | Posted 08/25/2026 Updated 08/25/2026 Discontinued 08/25/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 05/14/2026 Updated 05/14/2026 Discontinued 05/14/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)